IDEC Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2003

Location

Tokyo Japan

Primary Industry

Business Support Services

About

Founded in 2003 by Chris Brünger, chaired by Naoya Kato as CEO, and based in Tokyo, Japan, IDEC Inc., enables clients to develop and obtain regulatory approval for drug development programs, and have a virtual presence in Japan. As of 2021, the company has supported over 100 client projects with collaborations in North America, Europe, Middle East, and the Pacific. In 2020, Kinsale Holdings, Inc., a portfolio company of GHO Capital, acquired IDEC Inc. As of 2021, the company staffs over 23 employees. The company provides R&D services to design and confirm development strategies to support the client’s decision-making process as well as implementation capabilities to Japanese development programs with CROs and other local Japanese constituents. IDEC provides its services in a stepwise fashion that is to initially conduct a desktop assessment with existing data and IDEC intelligence, confirmation of strategy, implementation, and J-NDA submission, review, and approval.

Current Investors

Eliquent Life Sciences

Request a demo to show more

Primary Industry

Business Support Services

Sub Industries

Consulting Services

Website

www.idec-inc.com

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Deals

Deals Type
Add-on

Deal Status	Target (s)	Deal Date	Investor(s)	Seller(s)	Deal size (Mn)	Enterprise value (Mn)	Post-money valuation (Mn)	EBITDA multiple (x)	Revenue multiple (x)	Lead partner (s)
Completed	IDEC Inc.	24 Nov 2020

Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.